Multicenter phase II study of apatinib treatment for metastatic gastric cancer after failure of second-line chemotherapy.
about
Multicenter phase II study of apatinib treatment for metastatic gastric cancer after failure of second-line chemotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Multicenter phase II study of ...... e of second-line chemotherapy.
@en
Multicenter phase II study of ...... e of second-line chemotherapy.
@nl
type
label
Multicenter phase II study of ...... e of second-line chemotherapy.
@en
Multicenter phase II study of ...... e of second-line chemotherapy.
@nl
prefLabel
Multicenter phase II study of ...... e of second-line chemotherapy.
@en
Multicenter phase II study of ...... e of second-line chemotherapy.
@nl
P2093
P2860
P356
P1433
P1476
Multicenter phase II study of ...... e of second-line chemotherapy.
@en
P2093
Hanguang Ruan
Juan Xiong
Junlin Dong
Xiaolong Cao
Xiaoming Zhong
Xueliang Zhou
P2860
P304
104552-104559
P356
10.18632/ONCOTARGET.21053
P407
P577
2017-09-19T00:00:00Z